Last updated: July 29, 2025
Introduction
Patent CL2014001793, filed and granted in Chile, pertains to a specific pharmaceutical invention. This document analyzes the scope, claims, and overarching patent landscape to elucidate its strategic position within global and local pharmaceutical patent dynamics. Understanding this patent's coverage highlights its influence on market exclusivity, potential for licensing, and competition in the Chilean pharmaceutical sector.
Patent Overview and Filing Details
Patent CL2014001793 was filed in 2014 and granted by the Chilean Patent and Trademark Office (INAPI). The patent title, claims, and description focus on a novel pharmaceutical compound or a specific formulation, method of use, or manufacturing process designed to treat certain medical conditions—most often aligned with innovative or extended-use strategies for existing drugs.
Although the official patent document details are extensive, a general overview indicates that it covers a specific chemical composition, its medical application, or a manufacturing process that supports pharmaceutical efficacy or stability.
Scope of the Patent
The scope defines the patent's exclusivity rights and delineates what aspects of the invention are protected. In CL2014001793, the scope primarily revolves around:
- Chemical Composition or Formulation: A specific compound, derivative, or formulation that enhances therapeutic effect or manufacturing stability.
- Method of Use: The patent may protect a novel method or indication for administering the drug, potentially extending the patent's life via method claims.
- Manufacturing Process: A unique process that yields the compound or formulation with advantages such as purity, yield, or cost-effectiveness.
- Delivery Technology: If applicable, claims may cover specific drug delivery mechanisms, such as controlled-release systems or targeted delivery.
The patent’s claims enumeration details the breadth of protection, aiming to prevent unauthorized manufacturing, sale, or use of similar compositions or methods.
Claims Analysis
Examining the patent's claims provides insight into its enforceable scope and the strategic intent behind the invention. Typically, patents contain:
- Independent Claims: Broad statements safeguarding the core invention. They often cover the chemical composition or primary method.
- Dependent Claims: Specific embodiments or refinements that narrow the scope, such as particular concentrations, dosage forms, or optional components.
In CL2014001793, the first independent claim likely claims an innovative pharmaceutical compound characterized by unique structural features or a novel combination of known compounds. Subsequent independent claims might cover:
- An improved therapeutic method based on the compound.
- Specific dosage forms, such as tablets, injections, or topical formulations.
- Pharmaceutical compositions combining the active ingredient with excipients.
Dependent claims may specify particular substitution patterns on the chemical core, concentration ranges, or process parameters. These hierarchical claims aim to maximize enforceability and provide fallback positions during litigation or licensing negotiations.
Patent Landscape and Strategic Position
Global and Regional Patent Context
Chile's pharmaceutical patent landscape aligns with international standards, particularly TRIPS compliance. Patent CL2014001793's positioning within this landscape involves considerations of:
- Prior Art: Existing patents and publications that may limit the patent’s novelty. The compound or method must be distinct from prior disclosures.
- Filing Timeline: Filed in 2014, the patent’s expiry will likely be around 2034, considering standard 20-year terms, subject to maintenance payments.
- Overlap with International Patents: The inventors possibly filed PCT applications or under regional patents systems, such as the ARIPO or INPI, to secure broader protection.
Competitive Landscape
In the Latin American region, patentability hinges on novelty, inventive step, and industrial applicability. The patent may have counterparts or similar patents in key markets like the U.S., E.U., or Asia, which impact its strength in licensing negotiations or legal enforcement.
- Overlap with Existing Patents: If similar patents exist, they might challenge the scope of CL2014001793 or enable licensing agreements.
- Potential for Infringement: Competitors manufacturing similar formulations could infringe on the patent if they deviate structurally or methodologically.
Patent Clusters and Innovation Trends
This patent likely belongs to a cluster focusing on:
- Biopharmaceuticals: Monoclonal antibodies, peptides, or biologics if applicable.
- Chemical Innovation in Therapeutics: Small molecule derivatives designed for targeted therapy.
- Combination Products: Fixed-dose combinations expanding treatment options.
Understanding these clusters can reveal potential competitors or collaborators and inform strategic decisions about market entry, licensing, or R&D investments.
Implications for The Market and Stakeholders
- For Originator Companies: The patent secures exclusive rights to particular formulations or methods, providing a competitive edge.
- For Generics Manufacturers: The scope potentially limits generic entry unless the patent is invalidated, expired, or circumvented by design-around inventions.
- For Regulators and Policymakers: The patent supports local innovation but must be balanced with public health needs, considering patent term extensions or compulsory licensing.
Legal and Commercial Strategies
- Monitoring and Enforcement: Patent holders must vigilantly monitor for infringement and leverage legal mechanisms to enforce rights.
- Patent Term Management: Ensuring maintenance fees are paid to sustain enforceability until 2034.
- Patent Life Extension: Possibility of supplementary protection certificates in Chile or regional equivalents.
- Licensing and Partnerships: Opportunities to license the patent for market expansion within Latin America.
Conclusion
Patent CL2014001793 exemplifies strategic innovation within Chile's pharmaceutical patent landscape. Its scope likely encompasses novel chemical entities, methods of use, and manufacturing processes. Its strength hinges on detailed claim language, prior art landscape, and regional patent policies. Stakeholders must continuously evaluate its enforceability, overlapping patents, and evolving therapeutic trends to optimize their legal and commercial positioning.
Key Takeaways
- The patent covers a specific pharmaceutical composition or method, offering territorial exclusivity in Chile until approximately 2034.
- Detailed claim analysis reveals protections on chemical structure, formulation, and use methods, with dependent claims refining scope.
- The patent landscape indicates competitive and collaborative opportunities, influenced by regional and international patent activities.
- Maintaining enforceability entails diligent patent maintenance, monitoring infringement, and exploring licensing opportunities.
- Strategic alignment with regional patent policies and innovation trends determines long-term value and market access.
FAQs
1. What is the main inventive aspect protected by Chilean patent CL2014001793?
It primarily protects a novel pharmaceutical compound, formulation, or method of use designed to improve therapeutic efficacy or stability, though specific details depend on the patent claims.
2. How does this patent impact generic drug manufacturers in Chile?
It restricts the manufacturing and sale of similar formulations or methods until its expiration, unless challenged or invalidated. Generics may need to develop innovative alternatives or wait for patent expiry.
3. Can this patent be enforced outside Chile?
Protection is geographically limited but may be aligned with international filings or patents in other jurisdictions where similar inventions are filed.
4. How does patent scope influence licensing opportunities?
Broader claims provide more licensing leverage, while narrow claims limit scope. Strategic negotiations depend on understanding the precise claim language and potential overlaps.
5. What strategies should patent holders pursue to maximize patent value?
Ensure proper patent maintenance, explore regional protections, monitor for infringement, consider patent term extensions, and pursue licensing or partnerships to expand market reach.
Sources
- Chilean Patent and Trademark Office (INAPI). Patent CL2014001793 documentation.
- WIPO Patent Database. International patent family data related to the invention.
- Regional patent filings and legal analysis reports.
